Ondrugdelivery
Ondrugdelivery, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in the United Kingdom and operates extensively across Europe and North America. Founded in 2015, the company has quickly established itself as a key player in drug delivery solutions, focusing on innovative technologies that enhance therapeutic efficacy and patient compliance. Specialising in the development of advanced drug delivery systems, Ondrugdelivery offers a range of unique products and services designed to optimise the administration of medications. Their commitment to research and development has led to significant advancements in the field, positioning them as a trusted partner for pharmaceutical companies seeking to improve their drug delivery methods. With a reputation for excellence and a strong market presence, Ondrugdelivery continues to drive innovation in the industry.
DitchCarbon Score
How does Ondrugdelivery's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Media Production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ondrugdelivery's score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ondrugdelivery's reported carbon emissions
In 2022, Ondrugdelivery reported emissions related to their products, specifically noting that each dose of their dry powder inhalers (DPIs) generates approximately 0.0095 grams of CO2e. While specific total emissions data for the year is not provided, this figure highlights the environmental impact of their product manufacturing. Currently, Ondrugdelivery has not established formal reduction targets or commitments under frameworks such as the Science Based Targets Initiative (SBTi) or the Carbon Disclosure Project (CDP). This indicates a potential area for growth in their climate strategy, as many organisations in the pharmaceutical and healthcare sectors are increasingly setting ambitious targets to reduce their carbon footprints. Overall, while Ondrugdelivery has made strides in understanding the emissions associated with their products, further commitments and measurable reduction initiatives would enhance their climate responsibility and align them with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ondrugdelivery is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
